During the past decade, Southeastern Gynecologic Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeastern Gynecologic Oncology" #1 sponsor was "Cephalon" with 2 trials, followed by "Southeastern Gynecologic Oncology" with 2 trials sponsored, "Accelerated Community Oncology Research Network" with 1 trials sponsored, "Pierian Biosciences" with 1 trials sponsored and "Telik" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Gynecologic Oncology" #1 collaborator was "Celgene Corporation" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Ortho Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Gynecologic Oncology" are "Ovarian Neoplasms" (2 trials), "Adenocarcinoma" (1 trials), "Cancer" (1 trials), "Chemotherapy Side Effects" (1 trials) and "Epithelial Ovarian Cancer" (1 trials). Many other conditions were trialed in "Southeastern Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "Southeastern Gynecologic Oncology" are "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abraxane" (2 trials), "Armodafinil 150 mg/day" (1 trials), "Bevacizumab" (1 trials), "Doxorubicin HCl Liposome Injection" (1 trials) and "MiCK Assay" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Gynecologic Oncology" are 5 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Gynecologic Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Southeastern Gynecologic Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Gynecologic Oncology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".